SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-029276
Filing Date
2022-05-24
Accepted
2022-05-24 16:05:18
Documents
13
Period of Report
2022-05-24
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea160549-8k_biomxinc.htm   iXBRL 8-K 32586
  Complete submission text file 0001213900-22-029276.txt   261516

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE phge-20220524.xsd EX-101.SCH 4213
3 XBRL DEFINITION FILE phge-20220524_def.xml EX-101.DEF 27455
4 XBRL LABEL FILE phge-20220524_lab.xml EX-101.LAB 38219
5 XBRL PRESENTATION FILE phge-20220524_pre.xml EX-101.PRE 26075
7 EXTRACTED XBRL INSTANCE DOCUMENT ea160549-8k_biomxinc_htm.xml XML 7452
Mailing Address 22 EINSTEIN ST., 5TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 5TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38762 | Film No.: 22956642
SIC: 2836 Biological Products, (No Diagnostic Substances)